Oxidative stress can induce abnormally higher levels of reactive oxygen species (ROS) production, which is a critical factor for tumorigenesis. 12, 13 Cigarette smokers are exposed to many types of oxidants, which can cause mitochondrial dysfunction, resulting in ROS production and the NF-κB, STAT3, and PI3K activation that promote cell proliferation during the malignant transformation. 14, 15 However, most of these studies are performed in cell lines or animal models, and the results may not reflect the real process of human bronchial epithelial cells. Currently, conventional in vitro models are based on culturing cells under static conditions, with a fixed concentration of media supplement, nutrition composition, or substances from cigarettes, which are far away from the real environments in vivo. Furthermore, there is no current ideal animal model to study on cigarette smoking-induced COPD and lung cancer, 16 and there are only few studies on the tumor-like transformation of bronchial epithelial cells from patients with COPD, because of limited resource. Therefore, there is an urgent need to establish a novel model with which we can investigate the molecular mechanisms underlying the process of continual cigarette smoking-induced tumor-like transformation of human nontumor bronchial epithelial cells from COPD patients.
Microfluidic chip technology has been used for sample preparation, biological and chemical reaction, separation, and tests with many advantages. 17, 18 Microfluidic chip-based cell cultures can continually supply the cells with fresh medium of oxygen and nutrition at a controlled flow rate. 19 In addition, microfluidic chip can be sued for high-throughput tests and has been widely used in the field of drug screening, single cell analysis, and cell signal pathway research. 20 Thus, the microfluidic chip may provide a unique and ideal platform to study the continual exposure of primarily cultured human bronchial epithelial cells to CSEs.
In this study, we built a microfluidic chip for continual exposure of primarily cultured human bronchial epithelial cells to CSE to investigate their tumor-like transformation and potential molecular mechanisms. We employed human nontumor bronchial tissues from 10 patients with lung cancer and smoking-related COPD to obtain bronchial epithelial cells because these nontumor bronchial tissues surrounding the tumor mass are already exposed to cigarette smoking and chronic inflammation. 21 We found that continual exposure to CSE promoted the tumor-like transformation of primarily cultured human nontumor bronchial epithelial cells in the microfluidics by inducing endoplasmic reticulum stress and ROS production, and activating the NF-κB and PI3K/AKT/mTOR signaling.
MATERIALS AND METHODS

The Fabrication of Microfluidic Chip
A microfluidic chip contained four parallel operating modules for simultaneous culture of four cell samples (Fig. 1A) and one module including a concentration gradient generator (CGG), six main channels (width 300 μm, height 100 μm), and 18 cell chambers (diameter 2.5 mm, height 100 μm, Fig. 1B ). The CGG included five cascaded-mixing stages that generated linear concentrations by adjusting the flow rate of two merging solutions in each stage through controlling channel length, which was proportional to fluidic resistance. When the cell culture medium and CSE were filled into channels by a syringe pump, the CGG theoretically produced at least six different concentrations of CSE media (with CSE proportions of 0:1:3:5:7:9). A microfluidic chip is shown in Figure 1C . The polydimethylsiloxane (PDMS) microfluidic chip was fabricated using a Sylgard 184 kit (Dow Corning, Midland, TX) by a standard soft lithography method. Briefly, PDMS was fabricated by replica molding against masters, and bonded to a glass slide that had been treated with oxygen plasma (150 mTorr, 50 W, 25s). The finished PDMS microfluidic chip was first treated with dehydrated alcohol then distilled water, and autoclaved at 120°C and 103.4kPa for 30 minutes.
Specimen Collection and Tumor-Adjacent Bronchial Epithelial Cell Culture
This study was approved by the Institutional Review Board and Human Ethics Committee of the First Affiliated Hospital of Dalian Medical University, and written informed consent was obtained from individual patients. A total of 10 patients with lung squamous carcinoma and surgical treatment were recruited in the First Affiliated Hospital of Dalian Medical University, China, from January 2013 to May 2013 (see Table, Supplemental Digital Content 1, http://links.lww. com/JTO/A607, which demonstrates the demographic and clinical data). The criteria for the enrollment of patients were as follows: (1) pathological identification of a lung squamous carcinoma; (2) a history of COPD with current lung function (FVE1/FVC less than 70%, 2011 GOLD); (3) a history of cigarette smoking for more than 40 pack-years; and (4) currently without any other respiratory disease, such as tuberculosis.
After surgical removal of tumor, the tumor-adjacent bronchial tissues were dissected and the connective tissue, mucus, and blood clot in the samples were removed. The remaining bronchial tissues were cut into small pieces of approximately 1 mm 3 and cultured on six-well plates precoated with placenta collagen IV (Sigma Aldrich, St. Louis, MO) in serum-free airway epithelial cell medium (Promocell, Heidelberg, Germany) at 37°C in a humidified atmosphere of 5% of CO 2 . The cells were exposed to fresh medium every other day until the cells reached 80% confluence. Subsequently, the structure of cells was examined by hematoxylin-eosin (H&E) staining, and the expression of cytokeratin 19 (CK19) was determined by immunofluorescent assay using specific antibody (Abcam, ab15463).
CSE Preparation
CSE was prepared, as described previously. 22 Briefly, the smoke from two lit cigarettes (Research Grade Cigarette, University of Kentucky) was collected into 50 ml serum-free medium using constant vacuum flow. The CSE solution was filtrated through a 0.22-μm pore filter and utilized in experiments within 30 min.
Continual Exposure of Human TumorAdjacent Bronchial Epithelial Cells to CSE in a Microfluidics
The tumor-adjacent human bronchial epithelial cells were harvested, adjusted to a density of 1 × 10 6 cells/ml in medium, and were injected into the cell inlets #1-#6 of the microfluidic chip using a syringe pump at a constant flow rate of 8 μL/min for 10 seconds. After the cells were attached, the cells were supplied with complete medium at a constant rate of 5 μL/min for 48 hours, by a syringe pump in a perfusion mode. When the cells reached 80% confluence, the cells were exposed to different concentrations of CSE in medium by simultaneously infusing medium and different concentrations of CSE stock solutions into the chip through the CSE inlet and medium inlet at a constant rate of 7 and 5 μL/min, respectively.
Proliferation and Apoptosis Assay of Human Bronchial Epithelial Cells
The impact of CSE on cell proliferation was determined using a Cell-Light EdU Apollo 488 in vitro Kit (Ribobio, Guangzhou Ribobio Company, China), according to the manufacturers' instruction. Briefly, cells (1000/chamber) were treated with, or without, CSE for 48 hours and labeled with EdU for 2 hours. The cells were fixed, stained for Apollo and DNA, and examined under a fluorescent microscope (Olympus IX71, Japan, magnification factor ×200). The effect of CSE on cell apoptosis was determined by staining with Hoechst33342 and propidium iodide staining (Sigma Aldrich).
The Detection of ROS and Its Related Signaling Pathways in the Cultured Human Bronchial Epithelial Cells
The levels of cytoplasmic ROS were characterized using a ROS Assay kit, according to the manufacturers' instruction (Beyotime Biotechnology, Jiangsu, China). Briefly, cells were treated with, or without, CSE for 48 hours and stained with DCFH-DA for 20 minutes by injecting fluorescent probe in medium (1:1000) into the chambers, followed by examining under a fluorescent microscope.
The impact of ROS on the GRP78, NF-κB, and PI3K expression was determined by immunofluorescent assays. Briefly, cells were pretreated with, or without, a ROS inhibitor N-acetylcysteine (NAC, 20 mM, Sigma ) for 12 hours and exposed to CSE for 3 hours. The cells were fixed with 4% paraformaldehyde, permeabilized, and blocked by 5% goat serum. Subsequently, the cells were stained with 1:200 diluted anti-GRP78 (Santa Cruz), anti-phospho-IRE1α (Abcam, ab48187), anti-phospho-IKKα (Beijing Biosynthesis Biotechnology, China), anti-NF-κB p65 (Abcam, ab7970), anti-cyclin D1 (Abcam, ab16663), anti-PI3Kp85 (Abcam, ab86714), anti-phospho-AKT (Cell Signaling Technology), and anti-phospho-mTOR (Santa Cruz) overnight at 4°C, respectively. After being washed, the bound antibodies were detected using Dylight488 or Dylight594-labeled secondary antibodies (1:400, Jackson ImmunoResearch Laboratories) at 37°C for 1 hour. The cells were examined and imaged under a fluorescence microscope.
The expression of GRP78, NF-κB, and PI3K in the lung cancer tissues was determined by immunohistochemistry 23 using antibodies against GRP78, NF-κB, and PI3K and the SP-9000 Histostain TM-Plus Kits (ZYMED).
Detection of E-cadherin and Vimentin Expression
The impact of CSE on the E-cadherin and Vimentin expression was determined by immunofluorescent assays. Briefly, the cultured cells in the chambers were pretreated with, or without, 20 mMNAC, GRP78 inhibitor 4-phenylbutyrate (4-PBA, 5 mM, Sigma), NF-κB inhibitor BAY11-7082 (2 μM, InvivoGen) or PI3K inhibitor LY294002 (50 μM, Sigma) for 12 hours and then exposed to CSE for 48 hours twice a week for 8 weeks. The cells were fixed, permeabilized, and stained with 1:200 diluted anti-Ecadherin (Epitomics) or anti-Vimentin (Abcam), and were visualized using Dylight488-labeled secondary antibodies, followed by examining under a laser scanning confocal microscope.
In addition, the relative levels of E-cadherin and Vimentin expression were determined by Western blot. Briefly, cells at 10 5 /well were cultured in six-well plates, pretreated, and treated for 8 weeks, as described earlier. The cell lysates were separated by SDS-PAGE and transferred to nitrocellulose membrane (Pall). After being blocked with 5% fat-free milk, the membranes were incubated with antibodies against E-cadherin (Epitomics, 1:1000), Vimentin (abcam, 1:1000), and glyceraldehyde 3-phosphate dehydrogenase (GAPDH, Sigma,1:5000), and the bound antibodies were detected using a Super Signal West Pico Kit (Thermo), followed by quantitatively densitometric analyses using the Eagle Eye II software.
Anchorage-Independent Growth Assay
The impact of CSE on anchorage-independent growth of human bronchial epithelial cells was examined. Briefly, after being exposed to CSE for 8 weeks, the cells at 2000/well were cultured in 0.3% low-melt agarose (Sigma) in complete medium that were overlaid on 0.6% agarose in six-well plates for 2 weeks. Individual cell colonies with more than 50 cells were counted under a microscope.
Chromosome Analysis
Cells were pretreated with, or without, inhibitors for 12 hours, as described above, and exposed to CSE for 48 hours twice a week for 8 weeks. The cells were treated with 0.04 μg/ml of colchicines for 4 hours and subjected to chromosome analysis. 24 
Statistic Analyses
All experiments were performed at least for three times. Data are expressed as the means ± SD. The difference among groups was analyzed by analysis of variance using SPSS13.0 for Windows software. p value less than 0.05 was considered statistically significant.
RESULTS
Culture of Human Bronchial Epithelial Cells on a Microfluidic Chip
To test the feasibility of a microfluidic chip for culturing cells, 10 surgical lung squamous carcinomas (Fig. 1Da) were obtained and their tumor-adjacent human bronchi (Fig. 1Db) were cut into small pieces. After culture of small pieces of nontumor tissues for varying periods, human bronchial epithelial cells migrated from the tissues, proliferated, and exhibited in single-layer growth (Fig. 1E) . The cells displayed a typical structure of lung epithelial cells and expressed CK19, an indicative of epithelial character (Fig. 1F) . After incubation of the cells in the microfluidic chambers supplied with continually flowing medium for 2 weeks, the cells remained in epithelial structure (Fig. 1Ga) and approximately less than 10% of the cells only underwent apoptosis (Fig. 1Gb) . In addition, we observed that the cells from most of the samples survived about 10 weeks in the microfluidic chip. These observations clearly demonstrated that the established microfluidic chip was successful to culture human primary nontumor bronchial epithelial cells.
The Effect of CSE on Cell Proliferation and Apoptosis
To investigate the effect of continual CSE exposure on the survival, human bronchial epithelial cells were continually exposed to medium containing different percentages (2.37-91.88%) of CSE for 48 hours and the percentages of cell proliferation and apoptosis were quantitatively analyzed in Figure 2A . Treatment with lower doses (2.37-12.28%) of CSE seemed to stimulate human epithelial cell proliferation in a dose-dependent manner, but did not trigger cell apoptosis. In contrast, treatment with higher doses (19.86-91.88%) of CSE induced human bronchial epithelial cell apoptosis in a dose-dependent manner. A similar pattern of cell proliferation and apoptosis was observed by fluorescent staining (Fig.  2B,C) . Interestingly, treatment with lower doses of CSE for 3 or 8 weeks continually stimulated human bronchial epithelial cell proliferation in the microfluidic chip (Fig. 2D) . Therefore, continual exposure to different doses of CSE had opposite effects on the proliferation and survival of primarily cultured human bronchial epithelial cells.
Continual Exposure to CSE Induces ROS Production and Activates the Relevant Signal Pathways in Primarily Cultured Human Bronchial Epithelial Cells
Cigarette smoking induces oxidative stress. Next, we tested the effect of continual exposure to CSE on the ROS production and relevant signaling. The isolated bronchial epithelial cells were treated with different concentrations of CSE for 3 hours and stained with DCFH-DA. The mean intensity of fluorescent staining in the cells from individual patients was quantitatively analyzed in Figure 3A . Apparently, treatment with CSE induced ROS production in a dose-dependent manner and a representative pattern of fluorescent images from the case 5 is shown in Figure 3B . Analysis of the ROS-related signaling revealed that increased levels of GRP78 expression and IRE1α phosphorylation were detected in the cells following treatment with CSE for 30 minutes. The IKKα phosphorylation, NF-κB nuclear translocation, and cyclin D1 expression were detected in the cells at 1 hour post CSE exposure. Similarly, increased levels of PI3K expression, AKT and mTOR phosphorylation were also detected in the cells at 1 hour post CSE exposure (Fig. 4A) . However, in comparison with that in the cells without exposure to CSE or NAC, there was no obvious change in the levels of GRP78 and PI3K expression and NF-κB phosphorylation in the cells that had been treated with NAC before exposure to CSE (Fig. 4B) . Hence, these data suggest that continual exposure to CSE induced ROS production, which sequentially activated the GRP78/IRE1α, NF-κB, and PI3K/AKT/mTOR pathways in primarily cultured human bronchial epithelial cells in vitro.
To understand the importance of the activation of these pathways, we characterized the GRP78, PI3K, and NF-κB expression in 10 lung cancer samples by immunohistochemistry (see Figure, SDC 2, http://links.lww.com/JTO/A608, which demonstrates the expressions of GRP78, PI3K, and NF-κB in lung cancer tissues). There were obviously higher levels of GRP78, PI3K, and NF-κB expression in the carcinoma areas, when compared with that in the paracarcinoma areas. There were seven of 10 samples with positive staining for anti-GRP78, eight with positive staining for anti-NF-κB, and five with positive staining for anti-PI3K. These data suggest that aberrant activation of the GRP78/IRE1α, NF-κB, and PI3K/ AKT/mTOR pathways induced by continual exposure to CSE may reflect the tumor-like transformation of primarily cultured human bronchial epithelial cells in our experimental conditions.
Low Dose of CSE Promotes the Process of EMT in Human Bronchial Epithelial Cells
Tumor cells can lose their epithelial characters and are subjected to the EMT process. Accordingly, we analyzed the relative levels of E-cadherin and Vimentin expression after continual exposure to CSE in human bronchial epithelial cells. We found that continual exposure to CSE for 3 weeks obviously reduced the levels of E-cadherin, but increased the levels of Vimentin expression in human bronchial epithelial cells, suggesting that continual exposure to CSE promoted the EMT process of human bronchial epithelial cells in the microfluidic chip (Fig. 5A) . Furthermore, continual exposure to CSE for 8 weeks enhanced the EMT process in human bronchial epithelial cells (data not shown). However, the reduced E-cadherin and increased Vimentin expression induced by CSE were not detected in the cells that had been pretreated with NCA, BAY11-7082, 4-PBA, or LY294002. A similar pattern of E-cadherin and Vimentin expression was detected in the different groups of cells by Western blot assays (Fig. 5B) . The modulation in the levels of E-cadherin and Vimentin induced by CSE exposure was abrogated by pretreatment with an inhibitor for ROS or relevant signaling. These two lines of evidence demonstrated that continual CSE exposure promoted the EMT process in human bronchial epithelial cells, which was mediated by ROS-related signaling.
Continual Exposure to CSE Induces Tumor-Like Transformation of Human Primary Bronchial Epithelial Cells
Tumor-like transformation of nontumor epithelial cells usually changes their structure. To determine the potential tumor-like transformation induced by continual exposure to CSE, we characterized the morphological changes in human bronchial epithelial cells longitudinally. After treatment with CSE (12.28%) for 3 weeks, there were some cells with condensed nuclei and abnormal nuclear-cytoplasmic ratios, accompanied by atypical mitoses in the CSE-exposed cells, but not in the cells that had been pretreated with the indicated inhibitor (Fig. 6A) . The percentages of abnormal cells increased with prolonged CSE exposure (data not shown). Furthermore, continual exposure to CSE for 4-6 weeks promoted multiple layers of cell growth, an indicative of the loss of contact inhibition (Fig. 6B) , which was not in the cells pretreated with an inhibitor indicated. In addition, continual exposure to CSE stimulated the colony formation and pretreatment with an inhibitor indicated either completely prevented or significantly reduced the numbers of cell colonies ( Fig. 6C and D) . These data indicated that continual exposure to CSE promoted the anchor-independent growth of human bronchial epithelial cells, an indicative of tumor-like transformation of human nontumor epithelial cells, which were associated with low amount of ROS production and related signaling.
Low Dose of CSE Causes the Chromosome Instability of Human Bronchial Epithelial Cells
To further demonstrate the tumor-like transformation of human bronchial epithelial cells induced by CSE exposure, human bronchial epithelial cells were treated with, or without, CSE for 8 weeks and their chromosomes were analyzed. The cells without exposure to CSE displayed diploid, whereas the CSE-exposed cells were hypodiploid or hyperdiploid (Fig. 6E) . Some CSE-treated cells exhibited abnormal chromosomes, such as dicentric chromosomes, and these abnormal chromosomes were not observed in the cells that had been pretreated with an inhibitor indicated. Quantitative analysis indicated that continual exposure to CSE induced a higher frequency of human bronchial epithelial cells with chromosome instability, which was abrogated by pretreatment with an inhibitor indicated (Fig.  6F) . The morphological changes, anchor-independent growth, and higher frequency of cells with chromosome instability, together with high levels of the EMT process, suggest that continual exposure to CSE may induces tumor-like transformation of human nontumor bronchial epithelial cells in vitro.
DISCUSSION
In this study, we built a microfluidic chip and established a cellular model of continual CSE exposure of human nontumor bronchial epithelial cells from 10 surgical samples from patients with lung squamous carcinoma and smoking-related COPD to investigate the potential mechanisms underlying tumor-like transformation. Our studies lead to the after novel discoveries: FIGURE 4. Continual cigarette smoke extract (CSE) exposure activates the GRP78, NF-κB, and PI3K pathways in human bronchial epithelial cells. Human bronchial epithelial cells were exposed to CSE (12.5%) and the GRP78, NF-κB, and PI3K signaling was detected by immunofuorescent staining at the indicated time points. Additional cells were pretreated with 20 mM NAC and exposed to CSE for 3 hours and the GRP78, NF-κB, and PI3K signaling was detected by immunofluorescent staining. Data shown are representative fluorescent images from 10 separate experiments. The GRP78 and NF-κB pathways were labeled by Dylight488 (green) and the PI3K pathway was labeled by Dylight594 (red, scale bar 10 μm). A, Longitudinal assays of the activation of GRP78, NF-κB, and PI3K pathways. (B) The activation of GRP78, NF-κB, and PI3K was abrogated by pretreatment with NAC.
First, continual exposure to different doses of CSE had dual effects on the proliferation and survival of primarily cultured human bronchial epithelial cells. Second, continual exposure to CSE induced ROS production in a dose-dependent manner and moderate levels of ROS were associated with tumor-like transformation of human nontumor bronchial epithelial cells by activating the GRP78, NF-κB, and PI3K pathways. Third, continual CSE exposure promoted the EMT process, anchor-independent growth, and higher frequency of cells with chromosome instability in human bronchial epithelial cells, which was abrogated by pretreatment with a ROS scavenger. Fourth, the microfluidic chip was an excellent platform for the investigation of malignant transformation of nontumor bronchial epithelial cells and had many advantages over conventional in vitro cellular models. Our results extended previous findings 25, 26 and support the notion that heavy smoking-related oxidative stress, endoplasmic reticulum (ER) stress, and associated inflammation are crucial for inducing tumor-like transformation of human nontumor bronchial epithelial cells in vitro.
COPD is an inflammatory lung disease associated with heavy smoking. During the pathogenic process, heavy smoking induces oxidative stress and ROS production. Previous studies have shown that high levels of ROS can trigger epithelial cell apoptosis, whereas low levels of ROS can stimulate the proliferation, invasiveness, and metastasis of lung cancer cells by activating the NF-κB, AP-1, PI3K, MAPKs, and others. 27 In this study, we found that continual exposure to different doses of CSE induced ROS production in human nontumor bronchial epithelial cells in a dose-dependent manner. Although continual exposure to higher doses of CSE to induce high levels of ROS triggered human bronchial epithelial cell apoptosis, continual exposure to lower doses of CSE to induce moderate levels of ROS promoted the proliferation of human bronchial epithelial cells. More importantly, continual exposure to low dose of CSE activated the GRP78, NF-κB, and PI3K pathways in human bronchial epithelial cells, which was abrogated by pretreatment with NAC. In addition, we detected aberrant activation of these pathways in the corresponding lung cancer tissues of these patients. Previous studies have shown that aberrant activation of the NF-κB and PI3K is crucial for malignant transformation of epithelial cells, 28, 29 and ER stress is associated with the development of COPD in heavy smokers and drug-resistance in lung cancer patients. 30, 31 It is possible that continual CSE exposure to produce moderate levels of ROS may promote tumor-like transformation of human nontumor bronchial epithelial cells. 32 It is well known that malignant cells can undergo the EMT process and anchorage-independent growth and show chromosome aberration and unequal structure. Although E-cadherin expression is usually attenuated in all three subtypes of EMT, Vimentin, a cytoskeletal marker, is often induced when EMT occurs. Recently, Vimentin is frequently used to indentify cells undergoing type 3 EMT in cancers. 33, 34 We found that continual CSE exposure increased the levels of Vimentin expression, but reduced the levels of E-cadherin expression in human bronchial epithelial cells, an indicative of the EMT process. Furthermore, continual CSE exposure promoted anchorageindependent growth of human bronchial epithelial cells and increased the frequency of cells with chromosome instability, accompanied by some cells with condensed nuclei, abnormal nuclear-cytoplasmic ratios, and atypical mitoses. These several lines evidence clearly indicated that continual exposure to moderate dose of CSE promoted tumor-like transformation of human primarily cultured nontumor bronchial epithelial cells in vitro. However, these tumor-like changes were abrogated by pretreatment with NAC, GRP78 inhibitor 4-PBA, NF-κB inhibitor BAY11-7082, and PI3K inhibitor LY294002. These data suggested that moderate levels of ROS and associated GRP, NF-κB, and PI3K activation induced by continual CSE exposure are crucial for tumor-like transformation of human bronchial epithelial cells. Therefore, these findings may provide new insights into the molecular mechanisms underlying the link of heavy smoking-related COPD with lung squamous carcinoma in humans. We are interested in further investigating whether continual exposure to CSE can also induce tumorlike transformation of human nontumor bronchial epithelial cells from nonsmoking patients with lung squamous carcinoma, from nontumor patients, and from nonsmoking nontumor patients. To the best of our knowledge, this was the first report on that continual CSE exposure to induce tumor-like transformation of human nontumor bronchial epithelial cells from patients with heavy smoking-related COPD and lung squamous carcinoma. Conceivably, therapeutic target oxidative stress, ER stress, and aberrant activation of these pathways may be valuable for prevention from the development of squamous carcinoma in heavy smoking-related COPD patients.
The microfluidic chip used in this study was a unique and ideal platform for studying the tumor-like transformation of bronchial epithelial cells induced by continual CSE exposure because the process of CSE exposure is similar to heavy smoking in humans. Its minute structure, high-oxygen permeable PDMS materials, and a continuously flowing medium can mimic a real microenvironment in vivo and meet the requirements of primarily cultured human bronchial epithelial cells. 18 Therefore, compared with that from conventional platform, the research results from the microfluidic chip may be more reliable and meaningful. Furthermore, this microfluidic chip we built can be sued for high-throughput screening for the potential signal pathways and therapeutic targets with time-lapse imaging. With one device, we tested four samples for several conditions simultaneously, which reduced the experimental errors. More importantly, the microfluidic chip allowed both the morphological tracing and the fluorescence marker detection to fulfill the dynamic observation of cultured cells and their signaling during the long-term exposure of a carcinogen. Indeed, we monitored three signal pathways, including eight factors in the cultured cells in real time only on a chip. The dynamics of the intracellular signaling in the cell from 10 specimens were recorded in a short period. Thus, this designed microfluidic chip is a unique platform for studying the proliferation, apoptosis, and tumor-like transformation of primarily cultured bronchial epithelial cells and other types of cells.
